Calcium Gluconate Global Market Report 2026

Calcium gluconate serves as a mineral supplement for treating or preventing calcium deficiencies and managing issues like hypocalcemia, osteoporosis, and specific muscle spasms. It functions by restoring the body's calcium reserves, which support bone strength and muscle performance. Doctors often give it intravenously or orally to normalize blood calcium levels.

The primary forms of calcium gluconate include liquid, tablet, powder, and gel. Liquid describes substances that flow easily and conform to their container's shape, known for their pourability and ability to adapt to the container's form. Available grades encompass pharmaceutical grade and food grade, applied in areas like food and beverage production, pharmaceuticals, nutraceuticals, cosmetics and personal care, and additional uses. End uses cover emulsifier, bulking agent, and thickening agent.

Tariffs have influenced the calcium gluconate market by increasing the cost of imported raw materials and active pharmaceutical ingredients, thereby affecting production costs for pharmaceutical and nutraceutical manufacturers. The intravenous and oral supplement segments, particularly in regions like north america and europe that rely on imports, are most impacted. However, tariffs have also incentivized local manufacturing and sourcing, promoting domestic production capacities and innovation in cost-effective formulations, potentially benefiting regional suppliers in the long term.

The calcium gluconate market research report is one of a series of new reports from The Business Research Company that provides calcium gluconate market statistics, including calcium gluconate industry global market size, regional shares, competitors with a calcium gluconate market share, detailed calcium gluconate market segments, market trends and opportunities, and any further data you may need to thrive in the calcium gluconate industry. This calcium gluconate market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The calcium gluconate market size has grown strongly in recent years. It will grow from $118.01 billion in 2025 to $126.96 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing prevalence of calcium deficiency, rising cases of osteoporosis among elderly, growing hospital and clinical infrastructure, expansion of pharmaceutical distribution networks, increasing awareness about bone health.

The calcium gluconate market size is expected to see strong growth in the next few years. It will grow to $165.39 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for nutraceuticals and dietary supplements, innovations in injectable calcium formulations, expansion of geriatric care and pediatric healthcare, adoption of preventive healthcare strategies, growth of emerging markets in asia-pacific. Major trends in the forecast period include rising incidence of hypocalcemia, growth in osteoporosis awareness programs, increasing adoption of intravenous supplements, expansion of nutraceutical and functional foods, development of pediatric and geriatric calcium formulations.

The rising prevalence of osteoporosis is anticipated to drive expansion in the calcium gluconate market. Osteoporosis is a condition marked by diminished bone density and fragility, heightening fracture susceptibility. Cases of osteoporosis are climbing because of inactive lifestyles, insufficient calcium consumption, hormonal shifts, and aging-related bodily changes. The calcium gluconate market aids osteoporosis treatment by supplying supplemental calcium to enhance bone durability and lower fracture chances. For instance, in March 2025, the British Pharmacological Society, a UK-based association, reported that in 2023, most patients on osteoporosis therapies were women: 90.9% for denosumab, 80.8% for bisphosphonates, 98.9% for SERMs, 99% for tibolone, and 86.8% for teriparatide. Thus, the growing osteoporosis incidence is fueling calcium gluconate market growth.

Rising healthcare spending is anticipated to boost the calcium gluconate market in the future. Healthcare encompasses the structured network of medical care, experts, infrastructure, and assets designed to sustain and enhance people's physical and mental health. This spending is climbing because of aging demographics, rising rates of chronic illnesses, progress in medical innovations, and greater expectations for superior care services. The calcium gluconate market aids these demands by offering an essential remedy for disorders linked to calcium deficiency, such as hypocalcemia, heart-related issues, and specific poisonings. For instance, in 2024, per projections from the Office for Budget Responsibility (OBR) and the UK Treasury-a UK-based independent public entity-the UK's allocated health budget is expected to hit £192 billion ($244.43 billion) for 2024/25, up from £182 billion ($231.70 billion) in 2022/23. Thus, escalating healthcare expenditures are fueling expansion in the calcium gluconate market.

Major companies in the calcium gluconate market are prioritizing the creation and regulatory approval of innovative calcium gluconate drug formulations to enhance treatment access, deliver superior therapeutic solutions, and better manage calcium deficiencies along with associated acute disorders; this process involves a multi-phase journey encompassing discovery, preclinical assessments, clinical trials, and regulatory scrutiny to confirm a drug's safety, efficacy, and adherence to health agency requirements prior to patient use-for instance, in September 2023, Amneal Pharmaceuticals Inc., a U.S.-based firm specializing in generics and specialty pharmaceuticals, secured U.S. FDA approval via an abbreviated new drug application (ANDA) for calcium gluconate in sodium chloride injection, which earned Competitive Generic Therapy status with 180-day exclusivity and is available in 1000 mg/50 mL and 2000 mg/100 mL small-volume parenteral bags for treating acute symptomatic hypocalcemia in pediatric and adult patients.

Major companies operating in the calcium gluconate market are Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, Solvay, Viatris Inc., Baxter International Inc., Fresenius Kabi USA, Hikma Pharmaceuticals Inc., Amneal Pharmaceuticals Private Limited, Amphastar Pharmaceuticals, Jost Chemical Co., American Regent Inc., Coyne Chemical, Anhui Xingzhou Medicine Food Co. Ltd., Westco Chemicals Inc., Noah chemicals, ND Biotech Pvt Ltd, Global Calcium Private Limited, Foodchem, Pharma Cure Laboratories, Nivagen Pharmaceuticals Inc., Tianyi Food Additives Co. Ltd

Europe was the largest region in the calcium gluconate market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calcium gluconate market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the calcium gluconate market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The calcium gluconate market consists of sales of oral supplementation, calcium D-gluconate monohydrate, calcium D-gluconate gel and other injectable solutions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Calcium Gluconate Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses calcium gluconate market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for calcium gluconate ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The calcium gluconate market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Form: Liquid; Tablet; Powder; Gel
• 2) By Grade: Pharmaceutical Grade; Food Grade
• 3) By Application: Food And Beverage Manufacturers; Pharmaceutical; Nutraceutical; Cosmetic And Personal Care; Other Applications
• 4) By End Use: Emulsifier; Bulking Agent; Thickening Agent
• Subsegments:
• 1) By Liquid: Injectable Solution; Oral Liquid; IV Infusion
• 2) By Tablet: Standard Tablets; Effervescent Tablets
• 3) By Powder: Oral Powder; Injectable Powder
• 4) By Gel: Topical Gel; Transdermal Gel
• Companies Mentioned: Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Novartis AG; Eli Lilly and Company; Solvay; Viatris Inc.; Baxter International Inc.; Fresenius Kabi USA; Hikma Pharmaceuticals Inc.; Amneal Pharmaceuticals Private Limited; Amphastar Pharmaceuticals; Jost Chemical Co.; American Regent Inc.; Coyne Chemical; Anhui Xingzhou Medicine Food Co. Ltd.; Westco Chemicals Inc.; Noah chemicals; ND Biotech Pvt Ltd; Global Calcium Private Limited; Foodchem; Pharma Cure Laboratories; Nivagen Pharmaceuticals Inc.; Tianyi Food Additives Co. Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.